# OnCo record paper-aall1731-blinatumomab-children-nejm-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aall1731-blinatumomab-children-nejm-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aall1731-blinatumomab-children-nejm-2025" ;
  schema:name "Children's Oncology Group AALL1731: blinatumomab added to chemotherapy for children with standard-risk B-cell ALL"@en ;
  schema:description "Two courses of blinatumomab added to standard chemotherapy cut relapses in children with average- or higher-risk standard-risk leukaemia, raising three-year disease-free survival from 88% to 96%."@en ;
  schema:url <https://onco.cc/key-papers/paper-aall1731-blinatumomab-children-nejm-2025/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=AALL1731%20blinatumomab%20standard-risk%20B-ALL%20children%20Gupta%20NEJM%202025>, <https://clinicaltrials.gov/study/NCT03914625> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2411680> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Gupta S, Rau RE, Kairalla JA, et al." ;
  onco:related <https://onco.cc/pairings/blinatumomab-frontline-consolidation/>, <https://onco.cc/key-papers/paper-e1910-blinatumomab-mrd-negative-all-nejm-2024/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/all-paediatric-standard-risk/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:companies <https://onco.cc/companies/amgen/>, <https://onco.cc/companies/childrens-oncology-group/> ;
  onco:terms <https://onco.cc/terms/efs/>, <https://onco.cc/terms/mrd/> ;
  onco:trials <https://onco.cc/trials/aall1731/> ;
  onco:people <https://onco.cc/people/rachel-rau/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/>, <https://onco.cc/bottlenecks/b-survivorship/> ;
  onco:journals <https://onco.cc/journals/nejm/> .